Chemed Corp

476.02+5.21+1.11%Vol 138.79K1Y Perf -4.68%
Jul 30th, 2021 16:00 DELAYED
BID470.81 ASK0.0000
Open469.15 Previous Close470.81
Pre-Market- After-Market476.02
 - -  - -%
Target Price
592.50 
Analyst Rating
Strong Buy 1.25
Potential %
24.47 
Finscreener Ranking
★★+     48.94
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★+     48.79
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★+     64.80
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
★★+     42.73
Market Cap7.59B 
Earnings Rating
Buy
Price Range Ratio 52W %
41.10 
Earnings Date
27th Jul 2021

Today's Price Range

469.15477.62

52W Range

417.41560.00

5 Year PE Ratio Range

19.7057.70

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
-0.78%
1 Month
0.32%
3 Months
-0.12%
6 Months
-8.09%
1 Year
-4.68%
3 Years
50.62%
5 Years
224.11%
10 Years
719.48%

TickerPriceChg.Chg.%
CHE476.025.21001.11
AAPL145.860.22000.15
GOOG2 704.42-26.3900-0.97
MSFT284.91-1.5900-0.55
XOM57.57-1.3600-2.31
WFC45.94-0.5600-1.20
JNJ172.200.02000.01
FB356.30-2.0200-0.56
GE12.95-0.3400-2.56
JPM151.78-1.2200-0.80
Financial StrengthValueIndustryS&P 500US Markets
1.10
1.20
0.10
0.15
234.20
Leverage Ratio 1.60
ProfitabilityValueIndustryS&P 500US Markets
34.60
19.70
22.40
14.50
15.61
RevenueValueIndustryS&P 500US Markets
1.59B
99.62
3.37
4.90
DividendsValueIndustryS&P 500US Markets
0.28
1.36
5.89
6.87
Payout ratio6.00
Earnings HistoryEstimateReportedSurprise %
Q02 20214.454.603.37
Q01 20214.204.445.71
Q04 20205.145.13-0.19
Q03 20203.994.8621.80
Q02 20203.794.4116.36
Q01 20203.603.682.22
Q04 20194.134.222.18
Q03 20193.313.464.53
Earnings Per EndEstimateRevision %Trend
6/2021 QR4.452.77Positive
9/2021 QR4.330.23Positive
12/2021 FY17.511.04Positive
12/2022 FY19.301.85Positive
Next Report Date-
Estimated EPS Next Report4.45
Estimates Count2
EPS Growth Next 5 Years %7.40
Volume Overview
Volume138.79K
Shares Outstanding15.95M
Trades Count3.69K
Dollar Volume57.02M
Avg. Volume93.71K
Avg. Weekly Volume124.92K
Avg. Monthly Volume99.94K
Avg. Quarterly Volume90.51K

Chemed Corp (NYSE: CHE) stock closed at 476.02 per share at the end of the most recent trading day (a 1.11% change compared to the prior day closing price) with a volume of 138.79K shares and market capitalization of 7.59B. Is a component of Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Providers & Services industry, Healthcare sector and employs 15544 people. Chemed Corp CEO is Kevin J. Mcnamara.

The one-year performance of Chemed Corp stock is -4.68%, while year-to-date (YTD) performance is -10.63%. CHE stock has a five-year performance of 224.11%. Its 52-week range is between 417.41 and 560, which gives CHE stock a 52-week price range ratio of 41.10%

Chemed Corp currently has a PE ratio of 23.90, a price-to-book (PB) ratio of 8.24, a price-to-sale (PS) ratio of 4.80, a price to cashflow ratio of 15.50, a PEG ratio of 2.32, a ROA of 23.36%, a ROC of 32.43% and a ROE of 39.73%. The company’s profit margin is 15.61%, its EBITDA margin is 22.40%, and its revenue ttm is $1.59 Billion , which makes it $99.62 revenue per share.

Of the last four earnings reports from Chemed Corp, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $4.45 for the next earnings report. Chemed Corp’s next earnings report date is -.

The consensus rating of Wall Street analysts for Chemed Corp is Strong Buy (1.25), with a target price of $592.5, which is +24.47% compared to the current price. The earnings rating for Chemed Corp stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Chemed Corp has a dividend yield of 0.28% with a dividend per share of $1.36 and a payout ratio of 6.00%.

Chemed Corp has a Neutral technical analysis rating based on Technical Indicators (ADX : 19.49, ATR14 : 11.75, CCI20 : -20.75, Chaikin Money Flow : 0.05, MACD : -2.25, Money Flow Index : 46.24, ROC : 1.53, RSI : 50.00, STOCH (14,3) : 45.29, STOCH RSI : 0.86, UO : 45.10, Williams %R : -54.71), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Chemed Corp in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (75.00 %)
3 (75.00 %)
3 (75.00 %)
Moderate Buy
1 (25.00 %)
1 (25.00 %)
1 (25.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.25
Strong Buy
1.25
Strong Buy
1.25

Chemed Corp

Chemed Corp operates subsidiaries in two main segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue. It provides hospice and palliative-care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The vast majority of the segment's revenue is received from the Medicare and Medicaid reimbursement programs. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers. It also manufactures products and equipment used to provide these services. Chemed generates the majority of its revenue from business in the United States.

CEO: Kevin J. Mcnamara

Telephone: +1 513 762-6690

Address: 255 East Fifth Street, Cincinnati 45202-4726, OH, US

Number of employees: 15 544

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

58%42%

Bearish Bullish

57%43%

News

Stocktwits